UnknownNot Applicable

Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

Pakistan60 participantsStarted 2023-11-26

Plain-language summary

COMPARISON OF EFFICACY OF HYDROCORTISONE AND METHYLPREDNISOLONE IN ACUTE SEVERE ASTHMA In this study Investigator will compare the efficacy of hydrocortisone and methyl prednisolone in acute severe asthma that will lead to final result and beneficial effects that will help in early resoloution of symptoms and help in preventing recurrence

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Either Gender (18 to 50 years old) * Patient presenting to emergency department with acute severe asthma Exclusion Criteria: * Patients with critical illness or pregnant females. .Patient treated other than hydrocortisone and methylprednisolone. .Patients not willing to participate in study. * Life threatening asthma * Near fatal asthm

What they're measuring

Spirometry

Timeframe: 24 hours

Blood pressures

Timeframe: 24 hours

Respiratory rate

Timeframe: 24 hours

Heart rate

Timeframe: 24 hours

PEAK EXPIRATORY FLOW RATE

Timeframe: 24 hours

Trial details

NCT IDNCT06171932

SponsorUniversity of Karachi

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-01

View on ClinicalTrials.gov More Asthma Acute trials